URGENT NEED FOR VOLUNTEER DONORS - Low supply of type O red blood cells, AB plasma and Convalescent PlasmaBlood donation is safe and essential!  Recent changes to donor eligibility criteria may allow more to give. Please fill out the deferral/eligibility inquiry form if you have questions.

Potential donors who have received the COVID-19 vaccination are eligible to donate all blood products, including convalescent plasma with the following criteria.

Click here for our response to the Coronavirus Pandemic (COVID-19) including information from the U.S. Department of Homeland Security on blood donation being permitted during Stay at Home directives. Click here for care provider and self-referrals for convalescent plasma donors for those that had a positive molecular test (also called PCR or polymerase chain reaction) and are fully recovered from COVID-19.  Email or call 833-610-1025 with questions.

In addition to providing life-saving blood products and services to patients in need, the Blood Center works with doctors and scientists to evaluate new treatments, cellular therapy and improved methods for delivering transfusion medicine to communities. Our volunteer blood donors are ideal candidates to participate in research and clinical trials because they are healthy and engaged in helping improve the wellbeing of others. 


Patients who are prescribed this course of treatment will have immune cells collected through a process called apheresis. Once these cells are collected, they are immediately shipped to a Dendreon manufacturing facility where the cells are made into the patient's own personalized cancer treatment. The immune cells are then returned to the patient as a transfusable drug to fight prostate cancer. 


BioLinked is an electronic roster of people willing to participate in research studies. Those who wish to participate submit a confidential, self-managed, profile of only the medical and social information the participant is willing to offer. This allows BioLinked to then anonymously search to find people who meet research needs.